Decrease of fatty acid oxidation, ketogenesis and gluconeogenesis in isolated perfused rat liver by phenylalkyl oxirane carboxylate (B 807-27) due to inhibition of CPT I (EC 2.3.1.21).

No abstract is available for this paper.

• Publication year

  1985

• Venue

  European Journal of Biochemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1432-1033.1985.TB08661.XPMID 4038486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carbonyl-Co-A on mitochondrial oxidations.

  1984cited by this paper
• Metabolic changes in fed rats caused by chronic administration of ethyl 2[5(4-chlorophenyl)pentyl]oxirane-2-carboxylate, a new hypoglycaemic compound.

  1984cited by this paper
• Inhibition of carnitine palmitoyltransferase 1 by phenylalkyloxiranecarboxylic acid and its influence on lipolysis and glucose metabolism in isolated, perfused hearts of streptozotocin-diabetic rats.

  1984cited by this paper
• Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on carbohydrate and fatty acid metabolism in liver and muscle.

  1984cited by this paper
• The effects of valproate (2-n-propylpentanoate) on intermediate metabolism in isolated rat hepatocytes and intact rats

  1983cited by this paper
• The effect of malonyl-CoA on overt and latent carnitine acyltransferase activities in rat liver and adipocyte mitochondria.

  1983cited by this paper
• Synthesis and hypoglycemic activity of phenylalkyloxiranecarboxylic acid derivatives.

  1982cited by this paper
• Short-Term Regulation of Liver Metabolism

  1982cited by this paper
• Phenylalkyloxirane carboxylic acids, a new class of hypoglycaemic substances: Hypoglycaemic and hypoketonaemic effects of sodium 2-[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (B 807-27) in fasted animals

  1982cited by this paper
• Carnitine and carnitine palmitoyltransferase in fatty acid oxidation and ketosis.

  1982cited by this paper
• Malonyl CoA inhibition of carnitine acyltransferase activities

  1982cited by this paper
• Inhibition of mitochondrial β-oxidation at the stage of carnitine palmitoyltransferase I by the coenzyme A esters of some substituted hypoglycaemic oxiran-2-carboxylic acids

  1981cited by this paper
• Regulation of hepatic fatty acid oxidation and ketone body production.

  1980cited by this paper
• Evaluation of malonyl-CoA in the regulation of long-chain fatty acid oxidation in the liver. Evidence for an unidentified regulatory component of the system.

  1980cited by this paper
• Methyl 2-Tetradecylglycidate, An Orally Effective Hypoglycemic Agent that Inhibits Long Chain Fatty Acid Oxidation Selectively

  1979cited by this paper
• Inhibition of gluconeogenesis in isolated rat liver cells by methylenecyclopropylpyruvate (ketohypoglycin).

  1979cited by this paper
• Inhibition of fatty acid oxidation by 2-bromooctanoate. Evidence for the enzymatic formation of 2-bromo-3-ketooctanoyl coenzyme A and the inhibition of 3-ketothiolase.

  1979cited by this paper
• Interaction of mixed-function oxidation with biosynthetic processes. 1. Inhibition of gluconeogenesis by aminopyrine in perfused rat liver.

  1973cited by this paper
• Biochemical effects of the hypoglycaemic compound pent-4-enoic acid and related non-hypoglycaemic fatty acids. Effects of their coenzyme A esters on enzymes of fatty acid oxidation.

  1973cited by this paper
• Inhibition of gluconeogenesis in the isolated perfused rat liver by -phenylalkanoic acids.

  1973cited by this paper
• Specific inhibition of mitochondrial fatty acid oxidation by 2-bromopalmitate and its coenzyme A and carnitine esters.

  1972cited by this paper
• Biochemical effects of the hypoglycaemic compound pent--4-enoic acid and related non-hypoglycaemic fatty acids.

  1968cited by this paper
• Removal of fatty acids from serum albumin by charcoal treatment.

  1967cited by this paper
• Processing Data for Outliers

  1953cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• Untersuchungen uber die Harnstoffbildung im Tierkörper

  1932cited by this paper

• Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular Aging

  2024cites this paper
• Lactate utilization enables metabolic escape to confer resistance to BET inhibition in acute myeloid leukemia.

  2024cites this paper
• Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression

  2020cites this paper
• Extensive metabolic remodeling after limiting mitochondrial lipid burden is consistent with an improved metabolic health profile

  2019cites this paper
• Coordinate control of metabolic flux with liver energy status by AMPK in vivo

  2014cites this paper
• Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.

  2011cites this paper
• Uterine contractility is strongly influenced by steroids and glucose metabolism: an in vitro study on bovine myometrium

  2011cites this paper
• Regulatory enzymes of mitochondrial β‐oxidation as targets for treatment of the metabolic syndrome

  2010cites this paper
• The metabolic modulators, Etomoxir and NVP-LAB121, fail to reverse pressure overload induced heart failure in vivo

  2009cites this paper
• Structural insight into function and regulation of carnitine palmitoyltransferase

  2009cites this paper
• The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatment.

  2006cites this paper
• Insulin receptor, AMPK and CPT-2: Crystallization experiments and structural characterization of three proteins relevant to diabetes mellitus

  2006cites this paper
• Gluconeogenic-glycolytic capacities and metabolic zonation in liver of rats with streptozotocin, non-ketotic as compared to alloxan, ketotic diabetes

  2004cites this paper
• Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target

  2002cites this paper
• The Use of Partial Fatty Acid Oxidation Inhibitors for Metabolic Therapy of Angina Pectoris and Heart Failure

  2002cites this paper
• Coenzyme A Analogues and Derivatives: Synthesis and Applications as Mechanistic Probes of Coenzyme A Ester-Utilizing Enzymes.

  2000cites this paper
• Fatty acid import into mitochondria.

  2000cites this paper
• First clinical trial with etomoxir in patients with chronic congestive heart failure.

  2000cites this paper
• Selective modulation of carnitine long-chain acyltransferase activities. Kinetics, inhibitors, and active sites of COT and CPT-II.

  1999cites this paper
• Lipoic acid acutely induces hypoglycemia in fasting nondiabetic and diabetic rats.

  1999cites this paper
• Fatty acid activation.

  1997cites this paper
• On the effects of thia fatty acid analogues on hydrolases involved in the degradation of metabolisable and non-metabolisable acyl-CoA esters.

  1997cites this paper
• Asymmetric synthesis of (R)-(+)-etomoxir

  1997cites this paper
• Effects of the Carnitine-acyltransferase Inhibitor Etomoxir on Insulin Sensitivity, Energy Expenditure and Substrate Oxidation in NIDDM

  1997cites this paper
• The Effect of Inhibiting Fatty Acid Oxidation on Basal Glucose Metabolism

  1996cites this paper
• Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone.

  1996cites this paper
• Dexamethasone-induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation.

  1996cites this paper
• Oral Antidiabetic Drugs in Research and Development

  1996cites this paper
• Effects of refeeding diets on emeriamine-induced fatty liver in fasting rats.

  1996cites this paper
• Long-term administration of a sucrose-rich diet to normal rats: relationship between metabolic and hormonal profiles and morphological changes in the endocrine pancreas.

  1996cites this paper
• Influence of etomoxir on the expression of several genes in liver, testis and heart.

  1995cites this paper
• Cellular uncoupling induced by accumulation of long-chain acylcarnitine during ischemia.

  1994cites this paper
• Kinetics of 14(R,S)-fluorine-18-fluoro-6-thia-heptadecanoic acid in normal human hearts at rest, during exercise and after dipyridamole injection.

  1994cites this paper
• [Lipid metabolism and insulin resistance--clinical aspects and pathobiochemistry].

  1994cites this paper
• Inhibition of Long‐Chain Acylcarnitine Accumulation During Coronary Artery Occlusion Does Not Alter Infarct Size in Dogs

  1994cites this paper
• Recirculating, retrograde heart perfusion according to the Langendorff method for evaluation of MTG--methyl-2-tetradecylglycidate, McNeil 3716--cardiomyopathy.

  1993cites this paper
• Effect of Fatty Acid Oxidation Inhibition on Glucose Metabolism in Diabetic Rats

  1993influential citation
• Modification of subcellular organelles in pressure‐overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor

  1992cites this paper
• The Effect of Etomoxir on Insulin Sensitivity in Type 2 Diabetic Patients

  1992cites this paper
• Effect of etomoxiryl-CoA on different carnitine acyltransferases.

  1992cites this paper
• The diabetic heart: metabolic causes for the development of a cardiomyopathy.

  1992cites this paper
• Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes Mellitus

  1992cites this paper
• Fatty acid beta-oxidation in leukocytes from control subjects and medium-chain acyl-CoA dehydrogenase deficient patients.

  1992cites this paper
• The metabolic syndrome and signal transduction of gene expression.

  1991cites this paper
• Fatty acid accumulation during ischemia and reperfusion: effects of pyruvate and POCA, a carnitine palmitoyltransferase I inhibitor.

  1991cites this paper
• Inhibition by etomoxir of carnitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus.

  1991cites this paper
• Search for antidiabetic and cardioprotective drugs among inhibitors of β-oxidation (a review of the literature)

  1991cites this paper
• [Potentiation of the antiketogenic effect of exogenous glucose with the help of the new beta-oxidation inhibitor mildronate--3-(2,2,2-trimethylhydrazine)propionate].

  1991cites this paper
• New insights into the mitochondrial carnitine palmitoyltransferase enzyme system.

  1991cites this paper
• Characterization of a solubilized malonyl-CoA-sensitive carnitine palmitoyltransferase from the mitochondrial outer membrane as a protein distinct from the malonyl-CoA-insensitive carnitine palmitoyltransferase of the inner membrane.

  1990cites this paper
• On the mechanism of sodium 2-5-4 chlorophenylpentyloxirane-2-carboxylate (POCA) inhibition of hepatic gluconeogenesis.

  1990cites this paper
• Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation.

  1989cites this paper
• Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase.

  1989cites this paper
• Metabolic Inhibitors in the Treatment of Diabetes Mellitus

  1989cites this paper
• Substituted 2-oxiranecarboxylic acids: a new group of candidate hypoglycaemic drugs.

  1989cites this paper
• Interactions of inhibitors of carnitine palmitoyltransferase I and fibrates in cultured hepatocytes.

  1988cites this paper
• The Effect of Etomoxir on Glucose Turnover and Recycling with [1-14C], [3-3H]-Glucose Tracer in Pigs

  1988cites this paper
• Additive Hypoglycemic Effects of Drugs That Modify Free-Fatty Acid Metabolism by Different Mechanisms in Rats With Streptozocin-Induced Diabetes

  1988cites this paper
• Hypoglycaemic agents which do not release insulin.

  1987cites this paper
• Prevention of peroxisomal proliferation by carnitine palmitoyltransferase inhibitors in cultured rat hepatocytes and in vivo.

  1987cites this paper
• Evidence that the flux control coefficient of the respiratory chain is high during gluconeogenesis from lactate in hepatocytes from starved rats. Implications for the hormonal control of gluconeogenesis and action of hypoglycaemic agents.

  1987cites this paper
• Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors.

  1987cites this paper
• Glucose kinetics during acute and chronic treatment of rats with 2[6(4-chloro-phenoxy)hexyl]oxirane-2-carboxylate, etomoxir.

  1987cites this paper
• Active-site probes of carnitine acyltransferases. Inhibition of carnitine acetyltransferase by hemiacetylcarnitinium, a reaction intermediate analogue.

  1986cites this paper
• Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on intermediary metabolism in isolated rat-liver cells.

  1986cites this paper
• The Dependence of Electrophysiological Derangements on Accumulation of Endogenous Long‐Chain Acyl Camitine in Hypoxic Neonatal Rat Myocytes

  1986cites this paper
• Effect of various agents and conditions on palmitate oxidation by homogenates of rat liver and rat and human skeletal muscle.

  1985cites this paper
• Effect of various agents and conditions on palmitate oxidation by homogenates of rat liver and rat and human skeletal muscle.

  1985cites this paper